Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma (Q38677937)

5 September 2017

Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma (English)

1 reference

5 September 2017

13

Florin-Andrei Taran

0 references

Markus Wallwiener

9

object named as

Markus Wallwiener

0 references

Sara Brucker

12

object named as

Sara Y Brucker

1 reference

5 September 2017

Stefan Kommoss

1

1 reference

5 September 2017

Andreas D Hartkopf

2

1 reference

5 September 2017

Bernhard Krämer

3

1 reference

5 September 2017

Anne-Kathrin Bunz

4

1 reference

5 September 2017

Friederike Grevenkamp

5

1 reference

5 September 2017

Felix Kommoss

6

1 reference

5 September 2017

Jana Pasternak

7

1 reference

5 September 2017

Sabine M Arbabi

8

1 reference

5 September 2017

Markus Wallwiener

9

1 reference

5 September 2017

Annette Staebler

10

1 reference

5 September 2017

Sigurd F Lax

11

1 reference

5 September 2017

Florin-Andrei Taran

13

1 reference

5 September 2017

14 July 2017

1 reference

Journal of Cancer Research and Clinical Oncology

5 September 2017

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-017-2474-7

5 September 2017

0 references

cites work

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

Second Opinion Expert Pathology in Endometrial Cancer: Potential Clinical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

Early dissemination seeds metastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

L1CAM: amending the "low-risk" category in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

Unusual Epithelial and Stromal Changes in Myoinvasive Endometrioid Adenocarcinoma: A Study of Their Frequency, Associated Diagnostic Problems, and Prognostic Significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

Prevalence and prognostic value of disseminated tumor cells in primary endometrial, cervical and vulvar cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

Unusual patterns of endometrial carcinoma including MELF and its relation to epithelial mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-017-2474-7

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results

21 January 2018

1 reference

12 December 2020

Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up

1 reference

12 December 2020

MELF pattern invasion in endometrial carcinoma: association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion

1 reference

12 December 2020

Detection of disseminated tumor cells in patients with gynecological cancers

1 reference

12 December 2020

Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well-differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis

1 reference

12 December 2020

A standardized staining protocol for L1CAM on formalin-fixed, paraffin-embedded tissues using automated platforms

1 reference

12 December 2020

MELF invasion in endometrial cancer as a risk factor for lymph node metastasis

1 reference

12 December 2020

MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer

1 reference

12 December 2020

10.1007/S00432-017-2474-7

Identifiers

DOI

1 reference

5 September 2017

1 reference